• Find us on Facebook
  • Follow BMJ OnExamination on Twitter

Latest News

Like this article?

Click vote now

0

Highlights

from JAMA - 20 Aug 14



0

The Mental Health Comorbidities of Diabetes

from JAMA - 20 Aug 14

Individuals living with type 1 or type 2 diabetes are at increased risk for depression, anxiety, and eating disorder diagnoses. Mental health comorbidities of diabetes compromise adherence to treatment and thus increase the risk for serious short- and long-term complications, which can result in blindness, amputations, stroke, cognitive decline, decreased quality of life, and premature death. When mental health comorbidities of diabetes are not diagnosed and treated, the financial cost to societ



0

Avoiding Nocebo Effects to Optimize Treatment Outcome

from JAMA - 20 Aug 14

Converging evidence suggests that the occurrence of unwanted adverse events during drug treatment is in part determined by nonpharmacological effects. For instance, the majority of unwanted adverse effects and symptoms reported by patients in clinical trials often are not caused by the medication, because unwanted adverse effects can also occur to a comparable degree in the placebo group of the study. Similarly, the switch from brand name to generic drugs with identical compounds is frequently a



0

Interstate Medical Licensure Major Reform of Licensing to Encourage Medical Practice in Multiple States

from JAMA - 20 Aug 14

The Interstate Medical Licensure Compact is a streamlined process that would allow physicians to rapidly become licensed to practice medicine in multiple states. If the compact were to be approved by state legislators and incorporated into the laws of most, if not all, states, it could catalyze many substantial changes in medical practice. The potential benefits include easing the physician shortage in rural and other underserved areas and speeding the growth of telemedicine. Telemedicine, wheth



0

Beyond Conflicts of Interest Disclosing Medical Biases

from JAMA - 20 Aug 14

The editors of medical and scientific journals always ask authors of papers to declare any financial conflicts of interest (COIs) related to their research. There has recently been a shift away from allowing authors to decide what constitutes a financial COI toward asking them to disclose any potential perceived COI; some journal editors even ask authors to disclose any and all financial interests that they have. But there has also been a shift away from this focus on financial COIs toward a wid



0

Bronchiolitis, Deception in Research, and Clinical Decision Making

from JAMA - 20 Aug 14

Bronchiolitis is a viral lower respiratory tract infection characterized by increased respiratory effort and wheeze in young infants. Optimal clinical management has been difficult to define because bronchiolitis is a heterogeneous clinical condition and definitive research is lacking. During the past 3 decades, racemic epinephrine, bronchodilators, oral corticosteroids, inhaled corticosteroids, normal saline, and hypertonic normal saline have been suggested as potential therapeutic options for



0

Newborn Screening for Severe Combined Immunodeficiency Progress and Challenges

from JAMA - 20 Aug 14

September 30, 2014, marks the 50th anniversary of the Children’s Bureau recommendation for “the screening of all newborn infants for PKU [phenylketonuria] on a routine basis.” By 1968, 43 states had made screening for PKU mandatory. As a result of technological advances, newborn screening in the United States has been extended to as many as 37 core conditions in some states. As reported by Kwan and colleagues in this issue of JAMA, newborn screening for severe combined immunodeficiency (SCID) ha



0

Effect of Providing Conditional Economic Compensation on Uptake of Voluntary Medical Male Circumcision in Kenya A Randomized Clinical Trial

from JAMA - 20 Aug 14

ImportanceNovel strategies are needed to increase the uptake of voluntary medical male circumcision (VMMC) in sub-Saharan Africa and enhance the effectiveness of male circumcision as an HIV prevention strategy.ObjectiveTo determine whether small economic incentives could increase circumcision prevalence by addressing reported economic barriers to VMMC and behavioral factors such as present-biased decision making.Design, Setting, and ParticipantsRandomized clinical trial conducted between June 22



0

Effect of Oximetry on Hospitalization in Bronchiolitis A Randomized Clinical Trial

from JAMA - 20 Aug 14

ImportanceRoutine use of pulse oximetry has been associated with changes in bronchiolitis management and may have lowered the hospitalization threshold for patients with bronchiolitis.ObjectiveTo examine if infants with bronchiolitis whose displayed oximetry measurements have been artificially elevated 3 percentage points above true values experience hospitalization rates at least 15% lower compared with infants with true values displayed.Design, Setting, and ParticipantsRandomized, double-blind



0

Sustained Care Intervention and Postdischarge Smoking Cessation Among Hospitalized Adults A Randomized Clinical Trial

from JAMA - 20 Aug 14

ImportanceHealth care systems need effective models to manage chronic diseases like tobacco dependence across transitions in care. Hospitalizations provide opportunities for smokers to quit, but research suggests that hospital-delivered interventions are effective only if treatment continues after discharge.ObjectiveTo determine whether an intervention to sustain tobacco treatment after hospital discharge increases smoking cessation rates compared with standard care.Design, Setting, and Particip



0

Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States

from JAMA - 20 Aug 14

ImportanceNewborn screening for severe combined immunodeficiency (SCID) using assays to detect T-cell receptor excision circles (TRECs) began in Wisconsin in 2008, and SCID was added to the national recommended uniform panel for newborn screened disorders in 2010. Currently 23 states, the District of Columbia, and the Navajo Nation conduct population-wide newborn screening for SCID. The incidence of SCID is estimated at 1 in 100?000 births.ObjectivesTo present data from a spectrum of SCID newbor



0

Concussion and Female Middle School Athletes

from JAMA - 20 Aug 14

JAMA PediatricsConcussion Among Female Middle-School Soccer PlayersJohn W. O’Kane, MD; Amy Spieker, MPH; Marni R. Levy, BS; Moni Neradilek, MS; Nayak L. Polissar, PhD; Melissa A. Schiff, MD, MPHImportance Despite recent increased awareness about sports concussions, little research has evaluated concussions among middle-school athletes.Objectives To evaluate the frequency and duration of concussions in female youth soccer players and to determine if concussions result in stopping play and seeki





0

Seroprevalence of Herpes Simplex Virus Type 1 and 2 Among Pregnant Women, 1989-2010

from JAMA - 20 Aug 14

Genital herpes during pregnancy frequently complicates management, although neonatal herpes, a potentially catastrophic complication, is rare. Maternal acquisition of genital herpes simplex virus (HSV) type 1 or 2 near the time of delivery accounts for most cases of neonatal herpes. Neonatal HSV incidence has been stable in recent decades, although a shift toward more HSV-1 infections has been reported. Concurrently, a decline in HSV-1 seroprevalence, but not HSV-2, has been noted among reproduc



0

Tadalafil for Erectile Dysfunction Prevention After Radiotherapy for Prostate Cancer

from JAMA - 20 Aug 14

To the Editor Dr Pisansky and colleagues did not find any beneficial effect of daily tadalafil administration in preventing erectile dysfunction (ED) in men treated with radiotherapy for prostate cancer. Concerns about the methodology of this study parallel those raised after previous trials testing penile rehabilitation after radical prostatectomy. These include inadequate patient selection, short-term follow-up, and possibly improper tadalafil administration.



0

Tadalafil for Erectile Dysfunction Prevention After Radiotherapy for Prostate Cancer—Reply

from JAMA - 20 Aug 14

In Reply Although our study did not identify a role for tadalafil to prevent radiotherapy-related ED, Dr Castiglione and colleagues urge cautious interpretation of our results based on inadequate participant inclusion criteria and follow-up duration, and on possibly improper tadalafil administration. We do not agree that our participants’ favorable baseline (erectile function) profile negatively affected the trial’s outcome.



0

Statins and Ischemic Stroke

from JAMA - 20 Aug 14

To the Editor The report from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study indicated that the new equations for predicting atherosclerotic cardiovascular risk appeared to overestimate the risk of atherosclerotic events in the participants. This study affords an opportunity to assess a possible problem with the new Pooled Cohort risk equations.



0

Statins and Ischemic Stroke—Reply

from JAMA - 20 Aug 14

In Reply Based on published studies, we think there are clear benefits for statins for the primary and secondary prevention of stroke. The Cholesterol Treatment Trialists’ Collaboration meta-analysis from 2010 showed a hazard ratio of 0.85 (95% CI, 0.80-0.90) for stroke per 1-mmol/L reduction of low-density lipoprotein cholesterol with statin use vs placebo; 0.80 (99% CI, 0.73-0.88) for ischemic stroke, 1.10 (99% CI, 0.86-1.42) for hemorrhagic stroke, and 0.88 (99% CI, 0.76-1.02) for unknown str



0

Treatment for Opioid Use Disorder

from JAMA - 20 Aug 14

To the Editor The Viewpoint by Drs Olsen and Scharfstein addressed an important and timely topic, the stigma of opioid use disorder and its treatment. Olsen and Scharfstein appropriately emphasized the importance of medication-assisted treatment as a mainstay of intervention for and treatment of opioid addiction. However, while the therapeutic armamentarium for this disorder is limited, it is not as limited as Olsen and Scharfstein suggested.



0

Treatment for Opioid Use Disorder—Reply

from JAMA - 20 Aug 14

In Reply Dr Stoddard notes that our Viewpoint on the stigma associated with the treatment of opioid use disorder did not discuss naltrexone. In 2010, the US Food and Drug Administration approved the extended-release formulation of naltrexone for relapse prevention of opioid use disorder based on evidence of efficacy against placebo.



0

Incorrect Date

from JAMA - 20 Aug 14

In the Review article entitled “A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions” published in the April 2, 2014, issue of JAMA (2014;311[13]:1327-1335. doi:10.1001/jama.2014.1398), a date was incorrectly reported. In the third paragraph of the Results section, fifth sentence, “January 2014” should have read “February 2014.” This article was corrected online.



0

CDC: Major Disparities in Opioid Prescribing Among States Some States Crack Down on Excess Prescribing

from JAMA - 20 Aug 14

The first few months of 2010 marked a dramatic turn in Florida’s efforts to curb rampant “pill mills,” clinics that inappropriately prescribe large quantities of opioids for nonmedical reasons. The state required all pain clinics within its borders to register no later than January 2010. In that year, federal, state, and local law enforcement began a major crackdown, called Operation Pill Nation.



0

CDC: Ebola Risk to US Patients Is Low, But Clinicians Should Be on Alert

from JAMA - 20 Aug 14

As the number of cases and deaths increases in West Africa in the largest-ever outbreak of Ebola virus disease (EVD), the US Centers for Disease Control and Prevention (CDC) has issued a health alert to health care workers to take steps to help prevent the spread of the virus in the United States. Although the risk of the virus spreading outside of Africa is low, the agency said, it advised clinicians to obtain good travel histories of their patients to identify those with recent travel (within



 

965 items Page 1 of 39 1 2 3 4 5 6 7 8 9 10 >>

    Search

    Categories

    Keyword cloud

    Abstract back blood body brain breast cardiac cardiovascular chronic CI cohort Coupons diabetes Dog Ebola England Gene genetic pain participants protein reviews screening supplied weight

    Top news voters


    © 2014 BMJ Publishing Group Ltd . All rights reserved.